Study guide

2.3 Scenario Practice for Health Promotion

CPN Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: CPN Orientation and Exam Strategy

1.1 Current CPN Exam Facts 1.2 Eligibility, Application, and Scheduling 1.3 Blueprint Domains and Weighting 1.4 Question Style and Score Report Thinking 1.5 Study Calendar and Practice Plan

2 Chapter 2: Health Promotion

2.1 Health Promotion Overview 2.2 Core Workflows and Decision Points 2.3 Scenario Practice for Health Promotion 2.4 Common Traps in Health Promotion 2.5 Practice Drills and Readiness Markers

3 Chapter 3: Assessment

3.1 Assessment Overview 3.2 Core Workflows and Decision Points 3.3 Scenario Practice for Assessment 3.4 Common Traps in Assessment 3.5 Practice Drills and Readiness Markers

4 Chapter 4: Planning and Management

4.1 Planning and Management Overview 4.2 Core Workflows and Decision Points 4.3 Scenario Practice for Planning and Management 4.4 Common Traps in Planning and Management 4.5 Practice Drills and Readiness Markers

5 Chapter 5: Professional Responsibilities

5.1 Professional Responsibilities Overview 5.2 Core Workflows and Decision Points 5.3 Scenario Practice for Professional Responsibilities 5.4 Common Traps in Professional Responsibilities 5.5 Practice Drills and Readiness Markers

6 Chapter 6: Final Review and Test Day

6.1 Timed Practice Strategy 6.2 Last-Week Review Map 6.3 Exam-Day Checklist 6.4 After the Exam and Next Steps

2.3 Scenario Practice for Health Promotion

Key Takeaways Explain This Topic AI

The infant primary series (DTaP, IPV, Hib, PCV, RV) is given at 2, 4, and 6 months.

MMR, varicella, and Hepatitis A first doses are given at 12–15 months—not before 12 months.

Live vaccines (MMR, varicella) are contraindicated in severe immunocompromise and pregnancy.

Tdap, HPV, and meningococcal conjugate are the core 11–12 year adolescent vaccines.

Last updated: June 2026

The Routine Childhood Immunization Schedule

The CDC/ACIP schedule is the backbone of pediatric health promotion. The infant primary series clusters at 2, 4, and 6 months , with boosters in the second year and at school entry. Memorize the visit groupings rather than each vaccine in isolation.

  • Visit Vaccines routinely due
  • Birth HepB (dose 1)*
  • 2 mo DTaP, IPV, Hib, PCV, RV (rotavirus), HepB (dose 2)
  • 4 mo DTaP, IPV, Hib, PCV, RV
  • 6 mo DTaP, PCV, RV; IPV/Hib/HepB (3rd dose depending on product); annual influenza begins at 6 mo
  • 12–15 mo MMR (1st) , Varicella (1st) , HepA (1st) , Hib booster, PCV booster
  • 15–18 mo DTaP (4th)
  • 4–6 yr DTaP (5th), IPV (4th), MMR (2nd) , Varicella (2nd)
  • 11–12 yr Tdap , HPV (2-dose series), MenACWY (1st)
  • 16 yr MenACWY booster; MenB (shared decision)

*In late 2025, ACIP moved to shared clinical decision-making for the HepB birth dose in infants of confirmed HBsAg-negative mothers; infants of HBsAg-positive or unknown status still receive HepB plus HBIG within 12 hours of birth . Always verify the current CDC schedule before counseling.

Rotavirus is oral and live ; the series must start before 15 weeks and finish by 8 months 0 days .

Seasonal and antibody products fill out the calendar: RSV protection with the monoclonal antibody nirsevimab is recommended for infants entering or born during their first RSV season (typically October–March) if the mother did not receive the maternal RSV vaccine; annual influenza vaccine begins at 6 months (two doses the first season). Administer injectable vaccines per age- and site-specific technique: vastus lateralis (anterolateral thigh) for infants/young toddlers and the deltoid once the muscle is adequate (~toddler/preschool onward), using appropriate needle length for the child's size.

Contraindications, Precautions, and Myths

Knowing what is and is not a true contraindication is a recurring scenario:

Live vaccines (MMR, varicella, rotavirus, intranasal flu) are contraindicated in severe immunocompromise (e.g., high-dose steroids, chemotherapy, untreated HIV with low counts) and in pregnancy .

Anaphylaxis to a prior dose or vaccine component is a contraindication; a history of egg allergy is no longer a contraindication to influenza vaccine.

NOT contraindications (vaccinate anyway): mild illness with low-grade fever, current antibiotic use, prematurity (vaccinate by chronologic age), breastfeeding, and a family history of reactions.

Precaution: moderate/severe acute illness—defer until improved.

Give acetaminophen for fever after vaccination only if needed; routine pre-medication can blunt the antibody response. Use the catch-up schedule for missed doses—never restart a series; count valid prior doses. Administer multiple injections at one visit in separate sites; spacing them out only delays protection.

Worked Scenarios

Scenario 1: A 12-month-old presents for a well visit. Which new vaccines are due? The MMR, varicella, and Hepatitis A first doses begin at 12 months, often with Hib and PCV boosters. MMR and varicella are not given before 12 months in routine schedules (an earlier MMR dose for travel does not count toward the 2-dose series).

Scenario 2: A mother of a 2-month-old declines all shots over fear of 'too many at once.' The nurse explains that the immune system handles multiple antigens easily, that delaying leaves the infant vulnerable during the highest-risk period, and documents the discussion—respecting autonomy while correcting the myth.

Scenario 3: A 4-year-old on high-dose chemotherapy is due for the second MMR. Because MMR is a live vaccine and the child is severely immunocompromised , it is deferred ; inactivated vaccines and household contact ('cocooning') vaccination are emphasized instead.

The exam reward is choosing the answer that protects the child on schedule while honoring true contraindications—not the one that conveniently delays care.

Documentation, VIS, and Reactions

Federal law (the National Childhood Vaccine Injury Act ) requires that a current Vaccine Information Statement (VIS) be given to the caregiver before each dose, and that the nurse document the VIS date, vaccine, lot number, manufacturer, site, route, and the administering nurse . Serious adverse events are reported through VAERS . Teach families the expected, benign reactions—low-grade fever, fussiness, and local redness/soreness/swelling —and distinguish them from true allergy.

Comfort measures include a cool compress to the site, encouraging movement of the limb, and acetaminophen only if the child is uncomfortable.

Adolescent Catch-Up and Counseling

Adolescent scenarios test the 11–12 year platform : Tdap (replaces the childhood DTaP series booster), the HPV series (2 doses if started before the 15th birthday, otherwise 3 doses), and MenACWY with a booster at 16. Frame HPV as cancer prevention—best given before any exposure—to counter hesitancy. For a teen behind on shots, apply the catch-up schedule and minimum intervals, counting valid prior doses rather than restarting. The correct answer keeps the adolescent protected and uses the encounter (often the only annual visit) to complete overdue vaccines, again favoring on-time protection over deferral.

Which Vaccine Prevents Which Disease

The exam may flip the question and ask which vaccine prevents a named illness, so connect each product to its disease: DTaP/Tdap prevents diphtheria, tetanus (lockjaw), and pertussis (whooping cough); Hib prevents Haemophilus influenzae type b meningitis and epiglottitis ; PCV prevents pneumococcal pneumonia, sepsis, and meningitis; IPV prevents polio; MMR prevents measles, mumps, and rubella; varicella prevents chickenpox; HepB prevents hepatitis B (and its liver-cancer sequelae); HepA prevents hepatitis A; rotavirus prevents severe infant gastroenteritis/dehydration; HPV prevents cervical and

other HPV-related cancers; and MenACWY/MenB prevent meningococcal disease.

Pertussis questions are common because young infants are most vulnerable before their series is complete, which is why maternal Tdap in each pregnancy and household 'cocooning' are emphasized.

Cold Chain and Administration Safety

Finally, vaccine storage and handling is testable: maintain the cold chain , store most refrigerated vaccines at 2–8°C (36–46°F) , protect light-sensitive products, and never use expired or improperly stored doses. Confirm the right vaccine, dose, route, and site using the five rights, aspirate is not required for IM vaccines, and observe the patient for 15 minutes after administration for an immediate hypersensitivity reaction, with epinephrine available for anaphylaxis.